Agouron Pharmaceuticals reported a first-quarter loss of...

Agouron Pharmaceuticals reported a first-quarter loss of $532,300 on revenue of $171,600, compared to a loss of $75,700 on revenue of $114,000 over the same three months last year. The loss was attributed to high development costs related to Agouron’s drug design technology.